These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 31118142)

  • 21. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
    Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic-cardiomyopathy.
    Chung H; Park CH; Kim Y; Kim JY; Min PK; Yoon YW; Lee KA; Lee BK; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY
    Clin Cardiol; 2020 Nov; 43(11):1317-1325. PubMed ID: 32815161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.
    van Ooij P; Allen BD; Contaldi C; Garcia J; Collins J; Carr J; Choudhury L; Bonow RO; Barker AJ; Markl M
    J Magn Reson Imaging; 2016 Jan; 43(1):107-14. PubMed ID: 26227419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
    J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
    Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.
    Das A; Kelly C; Teh I; Nguyen C; Brown LAE; Chowdhary A; Jex N; Thirunavukarasu S; Sharrack N; Gorecka M; Swoboda PP; Greenwood JP; Kellman P; Moon JC; Davies RH; Lopes LR; Joy G; Plein S; Schneider JE; Dall'Armellina E
    Eur Heart J Cardiovasc Imaging; 2022 Feb; 23(3):352-362. PubMed ID: 34694365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.
    Zhou ZQ; He WC; Li X; Bai W; Huang W; Hou RL; Wang YN; Guo YK
    BMC Cardiovasc Disord; 2022 Feb; 22(1):25. PubMed ID: 35109817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
    Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B
    Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy.
    Malahfji M; Senapati A; Debs D; Angulo C; Zhan Y; Nagueh SF; Shah DJ
    Sci Rep; 2020 Sep; 10(1):15977. PubMed ID: 32994462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation.
    Rathod RH; Prakash A; Powell AJ; Geva T
    J Am Coll Cardiol; 2010 Apr; 55(16):1721-8. PubMed ID: 20394877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.
    Kwon DH; Setser RM; Popović ZB; Thamilarasan M; Sola S; Schoenhagen P; Garcia MJ; Flamm SD; Lever HM; Desai MY
    Int J Cardiovasc Imaging; 2008 Aug; 24(6):617-25. PubMed ID: 18204915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    Kamal MU; Riaz IB; Janardhanan R
    Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
    Fluechter S; Kuschyk J; Wolpert C; Doesch C; Veltmann C; Haghi D; Schoenberg SO; Sueselbeck T; Germans T; Streitner F; Borggrefe M; Papavassiliu T
    J Cardiovasc Magn Reson; 2010 May; 12(1):30. PubMed ID: 20492668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy.
    Sakamoto N; Kawamura Y; Sato N; Nimura A; Matsuki M; Yamauchi A; Kanno T; Tanabe Y; Takeuchi T; Natori S; Saijo Y; Aburano T; Hasebe N
    Heart Rhythm; 2015 Jun; 12(6):1276-84. PubMed ID: 25684235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation of Late Gadolinium Enhancement and Extracellular Volume Fraction to Ventricular Arrhythmias in Hypertrophic Cardiomyopathy.
    Levine J; Collins JD; Ogele E; Murtagh G; Carr JC; Bonow RO; Choudhury L
    Am J Cardiol; 2020 Sep; 131():104-108. PubMed ID: 32718552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI.
    Tseng WY; Dou J; Reese TG; Wedeen VJ
    J Magn Reson Imaging; 2006 Jan; 23(1):1-8. PubMed ID: 16331592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.